Company / Free Cash Flow per Share
Wave Life Sciences Ltd. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.23
FY2025
5-year range
-$2.41 / -$0.24
FY2021-FY2025
Trend
+3.6%
vs FY2024
Sector context
#108 of 192
Health Care
What the data says
At $-1.23, Wave Life Sciences Ltd.'s free cash flow per share ranks #108 of 192 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-5.60 in FY2020 to $-0.24 in FY2023.
Based on SEC 10-K filings.
-1.23 in FY2025.
Declined from $-0.24 to $-1.23 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#108 of 192 in Health CareTop 56% of 192This company -$1.23 Sector average -$19.84
▼
+93.8% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 3.6% year-over-year.
- Ranks #108 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2023.
- Lowest free cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.23 | +3.6% |
| FY2024 | -$1.28 | -439.5% |
| FY2023 | -$0.24 | +84.2% |
| FY2022 | -$1.50 | +37.8% |
| FY2021 | -$2.41 | +57.0% |
| FY2020 | -$5.60 | -60.8% |
| FY2019 | -$3.48 | -195.2% |
| FY2018 | -$1.18 | +73.0% |
| FY2017 | -$4.36 | -150.8% |
| FY2016 | -$1.74 | -106.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026